Related Experiment Video
Updated: Oct 11, 2025
A Mouse Model to Assess Innate Immune Response to Staphylococcus aureus Infection
Published on: February 28, 2019
Kaempferol inhibits the expression of α-hemolysin and protects mice from methicillin-resistant Staphylococcus
Abstract:
Staphylococcus aureus (S. aureus) is a common pathogenic bacterium that induces a variety of diseases in humans and animals. The significant pathogenicity of S. aureus is due to its expression of several virulence factors. Alpha-hemolysin (Hla) has attracted attention as a virulence factor in staphylococcal pathogenesis and has been the predominant focus of intense research. In this study, we found that kaempferol, a flavonoid compound, inhibited hemolysis at a low concentration (32 μg/mL) and exerted no effect on bacterial growth. Western blot and RT-qPCR assays further demonstrated that kaempferol downregulated the expression of Hla in S. aureus. We observed that kaempferol alleviated the damage from S. aureus Hla in A549 cells. More importantly, kaempferol showed a potent protective effect on mice pneumonia induced by MRSA, as evidenced by a significant improvement in the survival of mice, a reduction in the number of colonized colonies in lung tissue and a decrease in the pathological damage to lung tissues. In summary, the results demonstrate the protective effect of kaempferol on MRSA-induced lethal pneumonia in mice and indicate that kaempferol could be developed as a potential anti-MRSA drug.
Insights
Kaempferol, a flavonoid, effectively inhibits Staphylococcus aureus alpha-hemolysin without affecting bacterial growth. This compound demonstrates significant protective effects against MRSA-induced pneumonia in mice, suggesting its potential as an anti-MRSA drug.
Area of Science:
- Microbiology
- Pharmacology
- Biochemistry
Background:
- Staphylococcus aureus is a major human and animal pathogen.
- Alpha-hemolysin (Hla) is a key virulence factor contributing to S. aureus pathogenicity.
- Targeting virulence factors offers a strategy to combat bacterial infections.
Purpose of the Study:
- To investigate the effect of kaempferol on S. aureus virulence, specifically alpha-hemolysin (Hla).
- To evaluate the therapeutic potential of kaempferol against MRSA-induced pneumonia in a mouse model.
Main Methods:
- In vitro assays to assess kaempferol's effect on hemolysis and bacterial growth.
- Western blot and RT-qPCR to determine Hla expression levels.
- In vivo mouse model of MRSA-induced pneumonia to evaluate survival and lung pathology.
Main Results:
- Kaempferol inhibited S. aureus hemolysis at 32 μg/mL without impacting bacterial growth.
- Kaempferol significantly downregulated Hla expression in S. aureus.
- Kaempferol treatment alleviated Hla-mediated damage in A549 cells.
- Kaempferol administration improved survival rates, reduced bacterial load in lungs, and decreased lung tissue damage in mice with MRSA pneumonia.
Conclusions:
- Kaempferol effectively inhibits S. aureus alpha-hemolysin and mitigates MRSA-induced pneumonia in mice.
- Kaempferol demonstrates potential as a therapeutic agent against S. aureus infections, particularly MRSA.
- Further development of kaempferol as an anti-MRSA drug is warranted.
